Premenstrual syndrome: new insights into etiology and review of treatment methods
Top Cited Papers
Open Access
- 23 April 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1363875
Abstract
Premenstrual syndrome (PMS) is a common disorder affecting women of reproductive age, with an estimated global prevalence of 47.8%, with severe symptoms occurring in 3-8%, significantly affecting daily functioning. GABA conductance and changes in neurosteroid levels, particularly allopregnanolone, are suspected to play a substantial role in the disorder’s etiology. In this paper, we provide an overview of recent reports on the etiology and recognized therapeutic approaches, encompassing both pharmacological and non-pharmacological interventions. Our examination includes studies on SSRIs, hormonal agents, neurosteroids, supplementation, and therapeutic roles. We aim to determine the most favorable treatment regimen by comparing medication effects and alternative methods. The treatment of PMS is crucial for enhancing the quality of life for affected women. Medications used in PMS treatment should be individually selected to achieve the best therapeutic effect, considering the clinical situation of the patients.Keywords
Funding Information
- Uniwersytet Medyczny w Bialymstoku (B.SUB.24.445.)
This publication has 309 references indexed in Scilit:
- Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndromeCochrane Database of Systematic Reviews, 2017
- Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric DisorderJAMA Psychiatry, 2015
- Improvement of Primary Dysmenorrhea Caused by a Single Oral Dose of Vitamin D: Results of a Randomized, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 2012
- Time to Relapse After Short- or Long-term Treatment of Severe Premenstrual Syndrome With SertralineArchives of General Psychiatry, 2009
- Oral contraceptives containing drospirenone for premenstrual syndrome2009
- Oral contraceptives containing drospirenone for premenstrual syndrome2008
- Cochrane Database of Systematic ReviewsCochrane Database of Systematic Reviews, 2007
- Differential Response to Antidepressants in Women With Premenstrual Syndrome/Premenstrual Dysphoric DisorderArchives of General Psychiatry, 1999
- Biological, Social, and Behavioral Factors Associated With Premenstrual SyndromeArchives of Family Medicine, 1999
- Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group1997